Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT

President

CFO and COO

SVP Finance and CAO

General Counsel and Secretary

President and CEO

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ÃƒÅ¸7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ÃƒÅ¸7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avÃƒÅ¸8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with SchrÃƒÂ¶dinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-27	Premium	acquired	Premium	Premium	Premium	PRESIDENT
2024-01-16	Premium	sold	Premium	Premium	Premium	President
2024-01-16	Premium	sold	Premium	Premium	Premium	CFO and COO
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP Finance and CAO
2024-01-16	Premium	sold	Premium	Premium	Premium	CEO
2024-01-16	Premium	sold	Premium	Premium	Premium	General Counsel and Secretary
2024-01-14	Premium	acquired	Premium	Premium	Premium	President
2024-01-14	Premium	acquired	Premium	Premium	Premium	CEO
2024-01-14	Premium	acquired	Premium	Premium	Premium	CFO and COO
2024-01-14	Premium	acquired	Premium	Premium	Premium	General Counsel and Secretary
2024-01-14	Premium	acquired	Premium	Premium	Premium	SVP Finance and CAO
2024-01-13	Premium	acquired	Premium	Premium	Premium	President
2024-01-13	Premium	acquired	Premium	Premium	Premium	CFO and COO
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP Finance and CAO
2024-01-13	Premium	acquired	Premium	Premium	Premium	General Counsel and Secretary
2024-01-13	Premium	acquired	Premium	Premium	Premium	CEO
2023-11-13	Premium	bought	Premium	Premium	Premium	-
2023-11-13	Premium	bought	Premium	Premium	Premium	-
2023-09-07	Premium	sold	Premium	Premium	Premium	CFO and COO
2023-09-07	Premium	acquired	Premium	Premium	Premium	CFO and COO
2023-08-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-08-01	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-03	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-28	Premium	acquired	Premium	Premium	Premium	-

MORF - Morphic Holding Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MORF